NJ Weight Loss & Preventive Care

Semax

Patient Education Guide — What It Does, Why a Physician Would Prescribe It, and What the Evidence Says

NJ Weight Loss & Preventive Care Clinics PA
Physician's Offices: 420 Route 46 East Fairfield NJ 07004 & 1605 E Evesham Road Voorhees NJ 08043
(908) 598-0509  |  Jbock@njweightloss.us

📄 Download printable PDF This guide, print-ready 8.5×11 · works offline · save or share

← Back to the full Peptide Guide overview

Important Disclaimer — Read Before Using This Page

This information is not intended for use by unlicensed individuals or by licensed professionals who lack adequate training and experience in assessing patients for peptide or hormone therapy. All clinical decisions and dosing must be made in consultation with a licensed, experienced physician and a licensed, experienced compounding pharmacist, and should be supported by published clinical studies.

The information presented here has been compiled using Artificial Intelligence, statements from videos and websites by apparent qualified professionals, and available published research. We strongly encourage exhaustive independent research before considering any therapy. Anyone starting a medication they have never taken before should take an extremely conservative approach.

Nothing on this page or in these videos should be taken as medical advice. These materials are provided only to help begin your research. All dosing and treatment decisions should be made between you and your medical providers after proper evaluation. We are not affiliated with any of the doctors whose videos appear on this page.

Semax International Compounded

Also known as: N-Acetyl Semax (stabilized variant)
Category: Cognitive & Neurological Support — Nootropic Peptide

How it works. Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), modified with a Pro-Gly-Pro tail for stability and brain penetration. Critically, it acts on the nervous system without triggering corticosteroid release—it kept the neuroactive portion of ACTH and dropped the hormonal one. Its best-characterized mechanism is upregulation of brain-derived neurotrophic factor (BDNF), a protein central to neuronal growth, survival, and plasticity, along with modulation of dopaminergic and serotonergic signaling. It is typically administered intranasally, which delivers it to the central nervous system quickly and conveniently.

Why a physician might discuss it—and where the limits are. Semax was developed in Russia in the 1980s and is registered there for clinical use in conditions involving cognitive impairment and circulatory compromise, including the recovery period after ischemic stroke. In wellness contexts it is discussed for focus, mental stamina under stress, and cognitive support—without stimulant effects. The honest framing: the bulk of the human evidence is Russian clinical research, and rigorous Western replication is limited. It is not FDA-approved, and online intranasal products are overwhelmingly grey-market. As with Selank, it should never be used to sidestep proper evaluation of cognitive complaints, and psychiatric instability, pregnancy, and complex medication regimens are reasons to decline and refer.

What patients typically describe. Users commonly report improved focus and mental clarity within the first hour of intranasal administration, with effects lasting several hours; some describe cumulative benefits with cycled use. Nasal irritation and occasional headache are the most reported side effects. It is frequently discussed alongside Selank—Semax framed as the focus peptide, Selank as the calm peptide—which is exactly how the two appear together in our blended formulation.

Published Evidence: Russian randomized trials in acute ischemic stroke reported improved neurological recovery with intranasal Semax added to standard care. Mechanistic studies document rapid BDNF and NGF upregulation in the hippocampus and frontal cortex after intranasal administration in animal models, along with modulation of the melanocortin and monoamine systems. Western replication remains limited—an honest gap every patient conversation should acknowledge.
Key Study: Ashmarin IP, et al. "Semax, an analogue of ACTH(4-10): 20 years of study." Zh Vyssh Nerv Deiat. 1997; and Gusev EI, et al., trials of Semax in acute ischemic stroke, Zh Nevrol Psikhiatr.

Recommended Videos

Semax Explained: A Biochemical Perspective on The Cognition Peptide

Bioavailable — Semax Explained: A Biochemical Perspective on The Cognition Peptide

Semax: Everything You Need to Know — Benefits, Risks & Who Should Use It

Quinn Stillson, MD — Semax: Everything You Need to Know — Benefits, Risks & Who Should Use It

Semax: The Ultimate Guide to Cognitive Enhancement and Neuroprotection

Dr. Adam Sewell, MD — Semax: The Ultimate Guide to Cognitive Enhancement and Neuroprotection

Video Sources & Independence

The videos linked on this page are provided solely for educational purposes. None of the physicians or channels featured are sponsored by, affiliated with, or compensated by NJ Weight Loss & Preventive Care Clinics, its physicians, or any individuals associated with our practice. We have selected these videos because they offer thoughtful, evidence-based discussion of mechanisms and clinical considerations. Viewers should evaluate all sources independently.

← Back to the full Peptide Guide overview  ·  Peptide Dosing Reference →